Skip to main content
ToolGen Incorporated logo

ToolGen Incorporated — Investor Relations & Filings

Ticker · 199800 ISIN · KR7199800004 KO Professional, scientific and technical activities
Open in API
Filings indexed 309 across all filing types
Latest filing 2020-11-18 Report Publication Anno…
Country KR South Korea
Listing KO 199800

About ToolGen Incorporated

http://www.toolgen.com/eng

ToolGen Incorporated is a biotechnology company specializing in the development and application of genome editing technology. Founded in 1999, the company has developed multiple generations of gene editing tools, including Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), and the CRISPR-Cas9 system. ToolGen is a key patent holder for CRISPR-Cas9 technology, being the first to file a patent for its application in eukaryotic cells. The company's business model focuses on developing therapeutics and agricultural products, as well as monetizing its intellectual property through licensing and collaborations. Its primary mission is to translate genetic knowledge into transformative products for biomedicine and agriculture.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location, purpose, and target audience for the presentation. It is not the presentation itself, but rather a notification of the event, which falls under the category of general regulatory announcements or event notifications. Given the specific nature of the filing as an announcement of an IR event, it fits best under the 'RNS' (Regulatory Filings) category as a general corporate disclosure.
2020-11-18 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by the company ToolGen. It details the patent name, content, and its strategic importance. Since this is a specific regulatory announcement regarding corporate activity that does not fit into financial reporting, dividend, or management change categories, it falls under the general regulatory filing category.
2020-11-13 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by ToolGen. It details the patent name, content, holder, and utilization plan. Since it is a regulatory announcement regarding a specific corporate event (patent acquisition) that does not fit into financial reporting, M&A, or governance categories, it falls under the general regulatory filing category.
2020-10-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special related parties (e.g., Kim Jin-soo and others). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes.
2020-10-13 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '정정신고(보고)' (Correction Report) regarding '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options). It details changes to the number of recipients and the total number of shares granted due to employee resignations. This type of disclosure regarding stock option grants and subsequent amendments is a standard regulatory requirement for listed companies, falling under the category of general regulatory filings.
2020-09-25 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to the list of optionees and the number of shares granted due to employee resignations. This type of disclosure regarding stock option grants and subsequent amendments falls under general regulatory filings as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for capital changes). Therefore, it is classified as a Regulatory Filing (RNS).
2020-09-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.